Liver biopsy is considered the gold standard for diagnosing cirrhosis, but the researchers found a fourfold higher prevalence of cirrhosis among patients than shown by biopsy alone. Other clinical tests, including blood assessments and a non-invasive scoring system referred to as the FIB-4 rating, can reveal cirrhosis but are underused also, Gordon said. ‘There are several messages in our paper, and one is that if you’re simply counting on liver biopsy to establish a diagnosis of liver cirrhosis, you are going to be greatly underestimating the prevalence,’ he said. ‘One has to be suspect and try to seek out that diagnosis in any manner you can.’ Another liver disease expert agreed with this assertion. ‘For a long period we’ve recognized that there are limitations to what has been our gold standard in diagnosing cirrhosis.Upon further testing, the infant adult and wipe washcloth producer discovered that a few of their items contained Burkholderia cepacia, a species of antibiotic-resistant bacteria found in soil and water often, based on the U.S. Centers for Disease Control and Avoidance . Known for its vinegar-like odor, B. Cepacia offers emerged as a human respiratory pathogen in people with weakened immune systems or chronic lung disease, especially cystic fibrosis patients. Pulmonary infections concerning these bacteria can handle causing accelerated decline in lung features and will induce ‘cepacia syndrome,’ a progressive type of pneumonia that can be untreatable and fatal, according to MicrobeWiki.